Locations

DOYLESTOWN

Private financing in DOYLESTOWN, aggregated from public sources.

$614.1M
Capital raised
30
Companies
60
Rounds
2008
First on record
2025-12-10
Latest round

Rising DOYLESTOWN drew $56.1M over the last 12 months, up 233% versus the prior 12 ($16.9M). Of 29 companies rankable against same-niche peers, 31% model over-valued and 31% under-valued.

Capital flow over time

Quarterly capital raised in DOYLESTOWN.

2008-Q4 · $178K2008-Q42009-Q2 · $5.2M2009-Q3 · $406.0M2010-Q2 · $500K2010-Q4 · $480K2010-Q42011-Q1 · $1.5M2011-Q2 · $762K2011-Q3 · $833K2011-Q4 · $145K2011-Q42012-Q1 · $11.3M2012-Q3 · $39.0M2012-Q4 · $1.7M2014-Q1 · $200K2014-Q12014-Q3 · $1.4M2014-Q4 · $9.0M2015-Q1 · $1.9M2015-Q4 · $135K2015-Q42016-Q1 · $6.1M2016-Q3 · $734K2016-Q4 · $3.4M2017-Q1 · $1.1M2017-Q12018-Q2 · $875K2019-Q1 · $585K2019-Q4 · $100K2020-Q1 · $680K2020-Q12020-Q2 · $3.0M2020-Q3 · $5.0M2021-Q1 · $1.2M2021-Q2 · $22.4M2021-Q22021-Q3 · $1.3M2022-Q2 · $768K2023-Q1 · $948K2023-Q2 · $450K2023-Q22023-Q3 · $6.9M2024-Q1 · $400K2024-Q2 · $5.0M2024-Q3 · $16.5M2024-Q32025-Q2 · $331K2025-Q3 · $3.0M2025-Q4 · $53.1M
Sector mix
SectorCompaniesRoundsCapital
Biotechnology916$434.5M
Pharmaceuticals514$112.4M
Other Technology512$50.1M
Other Health Care410$6.7M
Healthtech11$4.4M
Cybersecurity11$2.5M
Fintech12$1.0M
Other22$880K
Top-funded companies
CompanySectorRaisedModeled value
Quantrx Biomedical CorpBiotechnology$406.0M$17.2B
Novira Therapeutics, Inc.Pharmaceuticals$48.0M$306.0M
Neuropathix, Inc.Pharmaceuticals$51.3M$270.8M
Prescient Medical IncBiotechnology$5.2M$187.1M
FORGE Life Science, LLCBiotechnology$3.6M$149.5M
Callidus Biopharma, Inc.Pharmaceuticals$11.3M$142.8M
NewIV Medical CorpHealthtech$4.4M$98.1M
Revolutionary Security LLCCybersecurity$2.5M$96.7M
Atrin Pharmaceuticals LLCBiotechnology$2.7M$66.6M
OnCore Biopharma, Inc.Pharmaceuticals$1.0M$47.3M
CrossCurrent Business Analytics, LLCComputers$833K$42.3M
Ory Corp.Other Technology$25.6M$40.7M
ExcaliVir, Inc.Biotechnology$734K$40.5M
ARdVRk Technologies, LLCSoftware / Tech$860K$36.4M
Powerlytics, Inc.Other Technology$10.8M$31.5M
Korio, Inc.Other Technology$12.3M$28.5M
FlowMetric, Inc.Other Health Care$3.4M$24.2M
Mid-Atlantic BioTherapeutics, Inc.Biotechnology$5.9M$23.3M
Cannae LlcOther Technology$940K$22.7M
Endo-Surgical Center of Florida, LLCOther Health Care$500K$15.4M
Other locations

Browse all locations or the full company rankings.

Frequently asked
How much venture funding have companies in DOYLESTOWN raised?
Companies based in DOYLESTOWN have raised approximately $614.1M across 60 recorded financing rounds among 30 companies, aggregated from public sources.
Is startup funding in DOYLESTOWN growing?
DOYLESTOWN funding is currently rising: capital raised over the last 12 months was up 233% versus the prior 12 months.
What sectors are most active in DOYLESTOWN?
The most active sectors in DOYLESTOWN by recorded financing are Biotechnology, Pharmaceuticals, Other Technology, Other Health Care. See the sector mix table for company and round counts.
Which are the most-funded companies in DOYLESTOWN?
The most-funded DOYLESTOWN companies in our coverage include Quantrx Biomedical Corp, Novira Therapeutics, Inc., Neuropathix, Inc., Prescient Medical Inc, FORGE Life Science, LLC. See the ranked table for disclosed capital and modeled valuations.